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Case Report
Rhnull: a rare blood group phenotype
Adnan Qureshi, Muhammad Salman, Bushra Moiz
Aga Khan University Hospital, Karachi.

Abstract
Rhnull phenotype is a rare blood group characterized
by the lack of expression of all Rh antigens (D, C, c, E and
e) on the red cells. The phenotype is further classified into
the regulator and amorph type based on underlying genetic
defect. The clinical significance of its recognition is that
such patients suffer from Rhnull syndrome associated with
osmotically fragile red cells called stomatocytes with
subsequent chronic haemolytic anaemia of varying degree.
Another importance is that such subjects readily form
alloantibodies on exposure to Rh antigens.
We report herein rare Rhnull phenotype in a young
pregnant female which was detected as a part of routine
antenatal work-up for red cell antibody screening and
identification.

Introduction
The Rh blood group system consists of at least 45
independent antigens and was first described in 1939. It is
one of the most polymorphic and immunogenic systems
and, next to ABO, is the most clinically significant blood
group in transfusion medicine.1
Rhnull phenotype (also referred to as Rhnull
syndrome or Rhnull disease) is a rare blood group with a
reported frequency of approximately 1 in 6 million
individuals.1 The characteristic hallmark of Rhnull
phenotype is the lack of all Rh antigens on the RBCs. In
addition to lacking Rh antigens, Rhnull cells also lack LW
and Fy5, and have a reduced expression of Ss, U, and
Duclos antigens.2 In Rhnull subjects the commonest
antibody formed in response to transfusion or pregnancy
reacts with all cells except Rhnull cells.3
The Rhnull is produced by at least two different
genetic mechanisms. The 'amorph' type is the result of
molecular change in RHCE gene with a deleted RHD gene,
whereas the more common 'regulator' type is associated
with the defect in RHAG gene. Both genotypes result in the
same clinical syndrome characterised by chronic
haemolysis of varying severity, with stomatocytosis,
spherocytosis, increased osmotic fragility, altered
phospholipids asymmetry, altered cell volume, defective
cation fluxes, and elevated Na+/K+ ATPase activity.1
In this report, we describe the rare Rhnull phenotype
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in a young female who was referred to our laboratory for
routine antenatal red cell antibody screening and
identification. To the best of our knowledge this is the first
case report of Rhnull syndrome from Pakistan.

Case Report
A 22-year-old pregnant female previously typed as
blood group A, Rh (D) negative with positive red cell
antibody screen was referred to AKUH clinical laboratory
for identification of antibody. Her past history was
significant for long-standing anaemia of mild to moderate
severity of unknown etiology that did not respond to
therapeutic trials with iron or other vitamin
supplementations. Her obstetrical history revealed that she
was second gravida. Her only previous baby was a healthy
two year old male child. There was no history of abortion,
miscarriage or any foetal loss. She had no history of
previous blood transfusion. Her family history revealed that
her parents had a consanguineous marriage and she had four
siblings, all were alive and well with no history of chronic
anaemia or any suspected blood disorder.
Her ABO and D blood types as well as red cell
antibody test were repeated. The test was performed on the
gel cards. It was observed that serum agglutinated
uniformly all four tested panel red cells, giving 4 + reactions
at room temperature, at 37ºC and at the antiglobulin phase.
The direct antiglobulin and auto-control tests were negative.
No red cell antibody was identified at this stage. This
prompted technologists to perform more detailed
serological workup including typing for various red cell
antigens.
Phenotypes
were
determined
by
haemagglutination in gel cards (DiaMed AG, Morat,
Switzerland) with monoclonal antibodies specific for Rh
(D, C, c, E, and e) antigens. These tests were confirmed in
duplicate and also rechecked by manual tube testing. Based
on serological studies, the patient's red cells were typed as
blood group A, Rh null (D -, C- , E-, c-, e-), Cw-, K+, Kpa,
Kpb+, Jsb+, Fya+, Fyb+, Jkb-, Lea-, Leb-, P1+, M+, N-, and
S-. Further blood samples were requested for
haematological studies which showed Hb: 10.8 gm/dl, Hct:
32.6%, MCV: 100 fl, MCH 25.9 pg: and MCHC 35.2 g/dl.
The platelets and differential white cell count were within
normal limits. The reticulocyte count was 9% and the
osmotic fragility of red cells was increased, with mean
corpuscular fragility (MCF) of 0.70 gm/dl after 24 hours
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incubation at 37°C (Normal range: 0.465 - 0.59 gm/dl).
Haemoglobin electrophoresis revealed normal HbA and
HbA2 with no elevation of HbF. Examination of the
peripheral smear showed numerous spherocytes, some
stomatocytes and polychromasia. These serologic and
haematological investigations enabled one to diagnose Rh
null phenotype in the patient. It was assumed that patient
had developed anti Rh antibodies presumably anti-Rh 29
which is the most common antibody detected in similar
settings. However, because of lack of sophisticated
facilities, further diagnostic serological or molecular work
up was not possible.

Discussion
Rh-deficiency syndrome results from the lack
(Rhnull), or severe reduction (Rhmod), of Rh blood group
antigens. This condition was first described in 1961 by Vos4
and his colleagues when a sample of blood completely
failed to react with various Rh antiseras. Three years later,
the term "Rhnull" was described by R. Ceppellini.5 To date
there are at least 43 persons belonging to 14 families with
Rhnull phenotype who have been reported in the literature. A
few Rhnull individuals were recognized because of the
presence of Rh antibodies in their sera while others were
detected with routine Rh phenotyping of the red cells.
Interestingly three cases were identified when the patients
were investigated for haemolytic anaemia and abnormal red
cell morphology.3
The disorder arises when individuals inherit, in an
autosomal recessive manner, either a suppressor gene
unrelated to the RH locus (regulator type) or a silent allele
at the locus itself (amorph type). Rhnull cells lack not only
Rh polypeptides (D and CE) but are also deficient in the Rh-
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associated glycoprotein (RhAG), glycophorin B, CD47 and
LW glycoprotein.6
Immunized Rhnull people in response to transfusion
or pregnancy have produced antibodies varying in
specificity from apparently straightforward anti-e or anti-C
to several examples that reacted with all red cells tested
except those from other Rhnull people. This antibody,
considered to be "anti-total Rh," has been given the
numerical designation anti-Rh29.3 In this report, the patient
probably got immunized during pregnancy or child birth
and the antibody present in patients sera reacted with all
cells tested and therefore was labeled as anti-total Rh (AntiRh29).
The clinical, haematological, and biological
abnormalities associated with this rare disorder indicate that
it affects the membrane integrity of red blood cells and
evident in this report with spherocytic haemolytic anaemia,
stomatocytosis and increased osmotic fragility of red cells.
Further genetic testing for the underlying mutation for
characterization of regular or amorph type and extended
family studies were not performed in this case because of
the non availability of relevant samples.
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